ADVERTISEMENT

Stay up to date every week with the european biotechnology newsletter.

✕
This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent

Stay up to date every week with the european biotechnology newsletter.

Log in here to read the desired article.

This field is for validation purposes and should be left unchanged.
This field is hidden when viewing the form
EBcom NL
This field is hidden when viewing the form
Consent
go to the article

go back to the homepage

  • Subscription
  • Newsletter
  • Advertise
European Biotechnology Magazine
biocom_logo
  • Latest news
  • Background
  • Opinion
  • The Mag
    • Issues
    • Special
    • Corporate publications
    • Subscribe
  • Euro Biotech Guide
  • Market Place
    • Products
    • Sponsored Publications
    • Advertise
  • Associations
  • Service
    • Newsletter
    • Contact Us
    • Editorial Team
  • Events
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

ADVERTISEMENT

SPONSORED PUBLICATIONS

© Becton Dickinson

The Difference of One Simple Sort

One researcher, one sorter, one cell, many discoveries. BD is dedicated to developing easy-to-use cell sorting technologies that simplify accurate and reliable flow cytometry. more ➔

Medicortex_Video.png

Crowdfunding campaign

Help Medicortex to develop a diagnostic kit for brain injury detection. more ➔

ADVERTISEMENT

OPIS

COMPASS Innovative web-platform developed by OPIS to manage Compassionate Use Programmes

Compassionate use is a treatment option that allows the use of an unauthorised medicine. more ➔

20161130-pressrelease-pharmatio.jpg

Performance in Clinical Trials: Pharmatio GmbH with new Portfolio

Pharmatio GmbH, already established in the monitoring and site liaison of clinical trials, has restructured its services. With Clinical Trial Liaison, the sponsors of clinical trials can ensure the patient … more ➔

DROOMS - Whitepaper

14 Must-Haves to Boost the Efficiency of Your Data Room

Stop wasting time with data room software that doesn’t really improve your workflow. more ➔

ADVERTISEMENT

The Jackson Laboratory

Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies

Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies. more ➔

RightsDirect

TOP3 CHALLENGES FOR COMMERCIAL TEXT MINERS

How Content Access and Manual Process Hinder Mining Efforts more ➔

placeholder

Humanized NSG and NSG-SGM3 mice as a new preclinical bridge for immune-oncology therapies.

Page 23 of 23«‹212223

LATEST NEWS

Suzhou, Jiangsu, China

Novartis bets up to $7.8B on Abogen’s mRNA autoim...

The Leadership Edit Thumbnail European Biotechnology

Pharming changes CEO, Evotec loses CSO and Nanobiot...

arthritis pain fingers

Amplio’s Phase 1b data hint at better first-line...

ADVERTISEMENT

MAGAZINE

1 / 4
EBM 3.2026 Autumn_cover

The autumn issue of European Biotechnology magazine asks what happens when biotech leaves Earth. Our cover story explores how microgravity could help researchers study disease, improve drug formulations … more ➔

2 / 4

The summer issue of European Biotechnology Magazine showcases the latest developments in drug delivery and RNA technologies. This issue features a list of eight venture capital firms to watch in 2026. … more ➔

3 / 4

The Spring 2026 issue of European Biotechnology Magazine presents a list of start-ups to watch in 2026 and explores other fascinating topics such as: Can biotechnology finally fix infertility? Can … more ➔

4 / 4
EB425_Cover

Europe is losing much of its expertise in deep tech and life sciences to the US. To prevent another generation of innovation from being lost, Europe must close the funding gaps. more ➔

SPONSORED PUBLICATION

1 / 3
Professor Jacob George, Chief Medical and Scientific Officer at the MHRA presenting his keynote speech at Phacilitate Advanced Therapies Europe, 2026
Cell & Gene Therapy

Europe’s CGT advantage at risk

Industry leaders at Advanced Therapies Europe 2026 warned that Europe must tackle barriers across commercialisation, regulation, reimbursement, manufacturing and patient access to retain its global … more ➔

2 / 3
Ute Kilger
intellectual property

G 1/25: Form over function and how expensive is it?

In proceedings before the European Patent Office (EPO), applicants are required to „adapt“ the description to the claims of a patent application once the claims are deemed allowable. The adaptation … more ➔

3 / 3
Ponchi Kantt-Neaz, Global Executive Business Director 3PBIOVIAN
Commercial Strategy

3PBIOVIAN appoints Ponchi Kantt-Neaz as Global Executive Business Director

The appointment of Ponchi marking an important milestone in the company’s global commercial strategy and further strengthening its commercial leadership as the company continues to expand its presence … more ➔

newsletter_link
Knowbio GmbH
  • Link to LinkedIn
  • Link to Instagram
  • Contact
  • Imprint
  • Privacy policy
Scroll to top Scroll to top Scroll to top